Market revenue in 2023 | USD 0.5 million |
Market revenue in 2030 | USD 1.1 million |
Growth rate | 12.5% (CAGR from 2023 to 2030) |
Largest segment | Neurology |
Fastest growing segment | Neurology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dental, Orthopedic, Neurology |
Key market players worldwide | GlaxoSmithKline, Hewlett Packard Enterprise Co, Merck KGaA, AstraZeneca PLC, Aprecia Pharmaceuticals, Extend Biosciences, BioDuro, Affini-T Therapeutics, Osmotica Pharmaceutical, FabRx, Cycle Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d printed drugs market will help companies and investors design strategic landscapes.
Neurology was the largest segment with a revenue share of 60% in 2023. Horizon Databook has segmented the South Africa 3d printed drugs market based on dental, orthopedic, neurology covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa's 3D printed drugs market is witnessing significant growth, driven by growing awareness regarding the potential of 3D printing technology in the healthcare sector. Moreover, South Africa's healthcare infrastructure is adopting this cutting-edge technology at a rapid rate. This has amplified the demand for 3D printing technology and related products.
Increasing investments in R&D initiatives are propelling advancements in 3D printing technology, resulting in more precise and efficient solutions. Moreover, South Africa's rising healthcare expenditure and the increasing prevalence of chronic diseases are propelling the demand for efficient drug manufacturing methods such as 3D printing.
In addition, growing government initiatives to accelerate the use of precision medicine are anticipated to boost market growth. For instance, since 2016, The South African Medical Research Council (SAMRC), in collaboration with the Department of Science and Innovation (DSI), has been driving the genomic/precision medicine initiative in South Africa.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa 3d printed drugs market , including forecasts for subscribers. This country databook contains high-level insights into South Africa 3d printed drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account